Pengfei Hu

2.4k citations
69 papers · 2.0k indexed · h-index 26
Topics
Osteoarthritis Treatment and Mechanisms (18 papers)Natural product bioactivities and synthesis (10 papers)Autophagy in Disease and Therapy (8 papers)
Journals
SHILAP Revista de lepidopterologíaBloodFrontiers in Plant Science
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Pengfei Hu

68 papers receiving 1.9k citations

Peers

Pengfei Hu
Comparison fields: 5 of 115
  • Molecular Biology 845
  • Rheumatology 518
  • Epidemiology 340
  • Pharmacology 323
  • Cancer Research 319
Replace Yaosen Wu with:
Yaosen Wu China
Colette Salvat France
Salahuddin Ahmed United States
Li‐Der Hsiao Taiwan
Vincent Braunersreuther Switzerland
Xiaojian Huang China
Terri Pietka United States
Amanda C. Doran United States
Chi Dae Kim South Korea
Don‐Kyu Kim South Korea
Pengfei Hu relative to Yaosen Wu China Yaosen Wu's profile →
Citations per field
00.5×1.5×
Yaosen Wu · 1×
Citations per year

Countries citing papers authored by Pengfei Hu

Since Specialization
Citations

This map shows the geographic impact of Pengfei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Hu more than expected).

Fields of papers citing papers by Pengfei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengfei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Hu. The network helps show where Pengfei Hu may publish in the future.

Co-authorship network of co-authors of Pengfei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Hu. A scholar is included among the top collaborators of Pengfei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Hu. Pengfei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 17
4 22
5 11
6 30
7 81
8 20
9 15
10 12
11 76
12 22
13 3
14 2
15 113
16 41
17 53
18 28
19 52
20 103

About Pengfei Hu

Pengfei Hu is a scholar working on Rheumatology, Cancer Research and Clinical Biochemistry, having authored 69 papers that have together received 2.0k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (18 papers), Natural product bioactivities and synthesis (10 papers) and Autophagy in Disease and Therapy (8 papers). The work is most often cited by research in Rheumatology (518 citations), Cancer Research (319 citations) and Pharmacology (323 citations). Pengfei Hu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Lidong Wu, Jiapeng Bao, Weiping Chen, Jingli Tang, Yan Xiong, Lifeng Jiang, Jie Feng, Dongwu Lai, Peilin Lu and Hong He. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Plant Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026